Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Titan Biotech Ltd Performance

Today's Low
480.00
arrowIcon
Today's High
515.00
52 Wk Low
230.00
arrowIcon
52 Wk High
618.00


Open

508.9

Traded Value (Cr)

56.80 L

Prev. Close

492.4

VWAP

496.8

Volume

11,581

Face Value

10

Titan Biotech Ltd Fundamentals

Market Cap
₹ 419 Cr
P/E Ratio (TTM)
16.90
P/B Ratio
3.46
Debt to Equity
0.07
ROE
17.25 %
EPS (TTM)
30.02
Dividend Yield
0.35%
Book Value
146.59

Click here to know more about Fundamentals

Titan Biotech Ltd Financials

Titan Biotech Ltd Financials

Titan Biotech Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 55.88 % 55.88 % 55.88 % 55.88 %
Retail 30.06 % 30.12 % 31.44 % 31.53 %
Others 14.06 % 14.00 % 12.68 % 12.59 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Promoters

55.88%

Retail

30.06%

Others

14.06%

FII

0.00%

Mutual Funds

0.00%

Promoters

55.88%

Retail

30.12%

Others

14.00%

FII

0.00%

Mutual Funds

0.00%

Promoters

55.88%

Retail

31.44%

Others

12.68%

FII

0.00%

Mutual Funds

0.00%

Promoters

55.88%

Retail

31.53%

Others

12.59%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹510.13

PIVOT

resistance-arrow
Resistance
First Resistance₹515.267
Second Resistance₹523.133
Third Resistance₹528.267
support-arrow
Support
First Resistance₹502.267
Second Resistance₹497.133
Third Resistance₹489.267
RSI48.354
MACD-4.563
ADX18.626
CCI-84.188

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day7,6355,96578.13
Week7,2625,53376.91
1 Month9,7817,68276.60
6 Months000.00

About Titan Biotech Ltd

Titan Biotech Ltd., the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities. The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals souced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries. During 2006-07, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 2009-10.

Managing Director

Naresh Kumar Singla

Founded

1992

NSE Symbol

Titan Biotech Ltd Management

NameDesignation
Naresh Kumar SinglaManaging Director
Suresh Chand SinglaManaging Director
Manju SinglaNon-Exec & Non-Independent Dir
Charanjit SinghCompany Sec. & Compli. Officer
Supriya SinglaNon-Exec & Non-Independent Dir
Rekha DalmiaNon-Exec. & Independent Dir.
Rohit JainChairman & Independent Directo
Abhishek AgarwalIndependent Director
Raja SinglaWhole-time Director

Titan Biotech Ltd News

Titan Biotech standalone net profit rises 173.33% in the December 2023 quarter
Sales rise 51.60% to Rs 45.98 crore
Titan Biotech consolidated net profit rises 119.94% in the December 2023 quarter
Sales rise 51.60% to Rs 45.98 crore
Titan Biotech to discuss results
On 12 February 2024
Titan Biotech consolidated net profit declines 28.59% in the September 2023 quarter
Sales rise 3.83% to Rs 43.43 crore
Titan Biotech to conduct board meeting
On 8 November 2023
Titan Biotech schedules AGM
On 29 September 2023
Titan Biotech consolidated net profit declines 17.87% in the June 2023 quarter
Sales decline 0.71% to Rs 34.75 crore
Titan Biotech to table results
On 10 August 2023
Board of Titan Biotech recommends final dividend
Of Rs 1.8 per share
Titan Biotech consolidated net profit declines 0.80% in the March 2023 quarter
Sales rise 11.84% to Rs 36.84 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,505.20
(0.79 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,337.00
(-1.60 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,791.10
(0.04 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,922.45
(0.74 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 982.20
(1.49 %)
36.23

Titan Biotech Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Titan Biotech Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Titan Biotech Ltd's share price is ₹490.50 as of May 10, 2024

Titan Biotech Ltd's P/E ratio is 16.90 times as of May 10, 2024.

Titan Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 3.46, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Titan Biotech Ltd's market is 419 Cr as on May 10, 2024.

The current financial records of Titan Biotech Ltd show a 17.25% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Titan Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Titan Biotech Ltd's 52-week high and low as of May 10, 2024 are ₹515 and ₹480 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Titan Biotech Ltd stands at 55.88%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.